Copyright
©The Author(s) 2024.
World J Transplant. Mar 18, 2024; 14(1): 87752
Published online Mar 18, 2024. doi: 10.5500/wjt.v14.i1.87752
Published online Mar 18, 2024. doi: 10.5500/wjt.v14.i1.87752
Variable | Survived, n = 141 (84.4) | Died, n = 26 (15.6) | P value |
Sex | 0.130a | ||
Male | 85 (60.3) | 11 (42.3) | |
Female | 56 (39.7) | 15 (57.7) | |
Nationality | 0.471a | ||
Bahraini | 127 (90.1) | 25 (96.2) | |
Non-Bahraini | 14 (9.9) | 1 (3.8) | |
Area of residency | 0.118b | ||
Northern | 63 (44.7) | 10 (38.5) | |
Capital | 29 (20.6) | 6 (23.1) | |
Southern | 25 (17.7) | 9 (34.6) | |
Muharraq | 24 (17.0) | 1 (3.8) | |
Age at liver transplant (yr) | 48.8 (13.2-58.0) | 57.5 (47.9-65.2) | 0.019c |
Age group | 0.346a | ||
Pediatric | 42 (29.8) | 5 (19.2) | |
Adult | 99 (70.2) | 21 (80.8) | |
Weight at transplant (kg), (n = 83) | 52.0 (20.0-70.0) | 8.0 (5.0-46.0) | 0.144c |
Height at transplant (cm), (n = 76) | 163.0 (149.0-169.0) | 138.0 (74.0-149.0) | 0.101c |
Presence of associated diseases | 139 (98.6) | 23 (88.5) | 0.255a |
Yes | 109 (78.4) | 21 (91.3) | |
No | 30 (21.6) | 2 (8.7) | |
Type of graft (n = 150) | 137 (97.2) | 13 (50.0) | 0.364a |
Living | 122 (89.1) | 13 (100) | |
Cadaveric | 15 (10.9) | 0 (0.0) | |
Donor-recipient relationship (n = 150) | 137 (97.2) | 13 (50.0) | 0.704a |
Related donors | 113 (82.5) | 10 (76.9) | |
Unrelated donors | 24 (17.5) | 3 (23.1) | |
Indications of liver transplantation | |||
Hepatitis C virus | 37 (26.2) | 5 (19.2) | 0.623a |
Primary sclerosing cholangitis | 18 (12.8) | 2 (7.7) | 0.743a |
Nonalcoholic steatohepatitis | 15 (10.6) | 4 (15.4) | 0.503a |
Hepatic cellular carcinoma | 14 (9.9) | 6 (23.1) | 0.092a |
Biliary atresia | 13 (9.2) | 3 (11.5) | 0.718a |
Hepatitis B virus | 13 (9.2) | 2 (7.7) | 1.000a |
Autoimmune hepatitis | 11 (7.8) | 1 (3.8) | 0.694a |
Metabolic diseases | 7 (5.0) | 0 (0.0) | 0.597a |
Intra- or post-LT complications (n = 150) | 138 (97.9) | 11 (42.3) | 0.537a |
Yes | 85 (61.6) | 8 (72.7) | |
No | 53 (38.4) | 3 (27.7) | |
Post-LT N-acetylcysteine use | 50/66 (75.8) | 46/52 (88.5) | 0.098 |
Liver transplant countries | 0.582b | ||
Middle East | 86 (61.0) | 19 (73.1) | |
Asia & Pacific | 51 (36.2) | 8 (30.7) | |
Europe | 4 (2.8) | 0 (0.0) | |
North America | 3 (2.1) | 0 (0.0) | |
Follow-up duration (yr) | 7.5 (3.9-10.6) | 1.5 (0.3-3.2) | < 0.001c |
- Citation: Isa HM, Alkharsi FA, Khamis JK, Hasan SA, Naser ZA, Mohamed ZN, Mohamed AM, Altamimi SA. Pediatric and adult liver transplantation in Bahrain: The experiences in a country with no available liver transplant facilities. World J Transplant 2024; 14(1): 87752
- URL: https://www.wjgnet.com/2220-3230/full/v14/i1/87752.htm
- DOI: https://dx.doi.org/10.5500/wjt.v14.i1.87752